Plain-English translation of NCT07345832 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach called VELO-S, a 12-week program designed to help older adults prevent or slow down sarcopenia—a condition where people lose muscle strength and mass as they age. The program combines personalized nutrition advice, physical activity recommendations, and support from trained volunteers, all delivered through a digital platform. You'll be compared to a control group that receives general health education instead, so researchers can see if the lifestyle program actually helps.
Sarcopenia is common in older adults and leads to falls, disability, and loss of independence—but many existing programs don't help people stick with lifestyle changes long-term. This trial was designed to solve that problem by using volunteers and digital tools to make the program more engaging and sustainable.
You likely qualify if…
You likely don't qualify if…
You'll be randomly assigned to either the VELO-S program or a control group. If you're in the VELO-S program, you'll receive personalized nutrition and exercise recommendations through a digital app, attend interactive workshops led by volunteers, and set personal goals over 12 weeks. The control group will receive educational materials on unrelated health topics, with similar contact and social engagement. Both groups will have their muscle strength, physical function, and overall health assessed at the start and end of the study.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Hong Kong